Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
about
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular eventsProgestogens in menopausal hormone therapyThe hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosisPharmacology of estrogens and progestogens: influence of different routes of administrationLipoprotein subclasses and endogenous sex hormones in women at midlifeSystemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women.Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype.Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner.Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsEvaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women.Novel agents for managing dyslipidaemia.Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones.New lipid-modifying therapies.Effect of hormone replacement therapy on cardiovascular disease: current opinion.Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause.Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease.Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.Lipoprotein(a) metabolism: potential sites for therapeutic targets.The cardiovascular effects of selective estrogen receptor modulators.The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention programDo Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?Lipoprotein(a): a promising marker for residual cardiovascular risk assessment.Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial.Hormone therapy and cardiovascular risk markers and disease: focus on progestagens.Type and route of estrogen administration.A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measuresEstrogen lowers triglyceride via regulating hepatic APOA5 expression.Hormone therapies and venous thromboembolism: where are we now?Primary prevention of cardiovascular disease with HRT.Lipoprotein(a): resurrected by genetics.Lipoprotein(a) as a therapeutic target in cardiovascular disease.Benefits and risks during HRT: main safety issue breast cancer.Dyslipidemia and cardiovascular disease in women.Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.Metabolic Adaptations in Pregnancy: A Review.17β-estradiol lowers triglycerides in adipocytes via estrogen receptor α and it may be attenuated by inflammation.The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy.Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
P2860
Q24629580-C34F5339-DB46-4FEC-B558-CC722072DE0DQ26795567-A28DE47E-CF57-4797-8318-75B921071D7FQ28263058-C2B2B800-4EF7-4391-9DEA-5A4C51DC1A0BQ28268346-558F5A71-7538-48CE-961E-29FC65C3D3B8Q33825076-6BEFB84A-D48B-40ED-A0BD-829BA5820F14Q33837130-C3FC3F30-91D2-472B-8527-A022153D75D7Q33909569-67305372-4441-4C90-AF7C-532E4BB9E101Q34086590-21543DB2-163D-4F7E-8FE8-D8B24135AFF5Q34211558-CA2BFD2C-46F9-4B83-88E9-0A698500C562Q34317537-661D6EDF-15B7-46D6-BD26-F2D76E0E2EE6Q34345640-01E1B02E-104A-45AA-B7CE-873D1DD30891Q34481800-4C9023DD-1C35-40D8-929B-D65EED53817BQ34758488-EE02CA4C-BC82-4E85-8951-7FD63628AF7EQ35073322-581ADFB3-02BA-44A1-B710-028ED9CE01BDQ35124691-2681150B-A9B4-472A-9E7A-79CA515019A8Q35595568-22C16D10-CEBA-472A-9238-D3F838F9C8D1Q35879090-2FC0EADD-77DC-4E08-AD83-9063094FCC8FQ36502941-893EEA0E-B4E4-499D-A2C2-8D12AC915D2CQ36539756-06EEDED3-6527-4C4C-9A03-16FFAD8DFBA1Q36739272-8D00A687-92D5-45C8-8AC6-1D4350BFF6FBQ37126271-07FEB9E6-46F5-460F-BDCD-3F5A602FF30EQ37143825-22DC7574-D6F8-426D-9228-0BA69C9BEF3FQ37285933-D34FCCE0-84F7-40F6-A970-98B83DBFF34EQ37487595-B0C3FADF-4CF0-4F17-83EC-4665A99A31C7Q37608577-3A0D5AAE-F29A-45AF-AA7C-25F6FD17043DQ37610402-B9656780-DECF-4569-88C9-CAA56EA49BF5Q37663969-DC0CB653-3F7E-4659-9873-8F1041A6CA2EQ37738026-EC6B6C19-032C-43AF-8398-E4D537769115Q37813184-2698C94F-4C6A-4FF3-A6E4-ADCD5D8E580FQ37968650-DF2ECA9B-4BAD-4423-8427-98041A541C18Q38045424-DD7A9DCA-02FA-44C6-8F8B-D4476EDA4D43Q38213476-784C7F5E-6436-4A75-9A42-E1F59EAC95C2Q38471535-CF3B8C06-4BDC-43CF-B8C6-16B61D4E556BQ38508952-6A8A47CA-3705-4597-B5D7-2F7761BD6C8DQ39054740-924CCFF6-BA2B-49F2-80A4-D972AB01E60AQ39180508-23E7BE8B-C09C-454B-A9DE-C79693CB71DFQ41991543-8CE79E0D-7F06-4BE9-A7A9-03081033CD4DQ42652062-55C72CBD-3BFC-4943-B2C9-74E1D9F4F139Q43073625-FB2DC249-BCCD-4AC5-ACD7-0D9A379A1497Q43089068-BA05C0A0-6919-4D6E-B4A7-A9CBEE5CCA30
P2860
Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Effects of postmenopausal horm ...... dies published from 1974-2000.
@ast
Effects of postmenopausal horm ...... dies published from 1974-2000.
@en
Effects of postmenopausal horm ...... dies published from 1974-2000.
@nl
type
label
Effects of postmenopausal horm ...... dies published from 1974-2000.
@ast
Effects of postmenopausal horm ...... dies published from 1974-2000.
@en
Effects of postmenopausal horm ...... dies published from 1974-2000.
@nl
prefLabel
Effects of postmenopausal horm ...... dies published from 1974-2000.
@ast
Effects of postmenopausal horm ...... dies published from 1974-2000.
@en
Effects of postmenopausal horm ...... dies published from 1974-2000.
@nl
P1476
Effects of postmenopausal horm ...... dies published from 1974-2000.
@en
P2093
Godsland IF
P304
P356
10.1016/S0015-0282(01)01699-5
P407
P577
2001-05-01T00:00:00Z